Studies exploring the effects of PDE5 inhibitors on insulin signaling pathways have shown promising results. Research published in the Journal of Sexual Medicine indicated that sildenafil enhances insulin signaling in skeletal muscle cells, potentially improving glucose uptake and utilization. Another study in the European Journal of Pharmacology suggested that sildenafil reduces insulin resistance in obese mice by enhancing NO-dependent signaling pathways.